Gastrointestinal Manifestations Among Patients With COVID19 | NCT04544150

Studies
Gastrointestinal Manifestations Among Patients With COVID19

NCT04544150

Sponsor

Assiut University

Status

Completed

Last Update Posted

Sep 10, 2020Actual

Enrollment

220Actual

Phase

Not provided

Conditions

Covid19

Interventions

Not provided

Countries

Egypt

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Sep 2020

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jun 1, 2020Actual

Primary Completion Date

Sep 1, 2020Actual

Completion Date

Sep 1, 2020Actual

First Submitted Date

Sep 8, 2020

First Submission Date that Met QC Criteria

Sep 8, 2020

First Posted Date

Sep 10, 2020Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Sep 8, 2020

Last Update Posted Date

Sep 10, 2020Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Ahmed Mohammed Abu Elfatth, Al-rahji University Hospital, Faculty of Medicine, Assiut, Egypt, Assiut UniversityPrincipal Investigator

Lead Sponsor

Assiut UniversityOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

many patients with confirmed infection with COVID-19 suffer from different symptoms and signs of gastrointestinal symptoms

Detailed Description

many patients with COVID1-9 infection experienced many intestinal symptoms mainly abdominal pain, vomiting, and diarrhea. This study aimed to assess the frequency of GIT manifestations among patients with COVID-19 and its impact on the outcome

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

220Actual

Name	Type	Description	Arm Group Labels	Other Names
	Other

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
frequency of GIT symptoms among patients with COVID-19 infection	any GIT symptoms in such patients were recorded	Baseline

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

all patients with COVID19

Exclusion Criteria:

patient refusal to participate in the study

Accepts Healthy Volunteers

Not provided

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

all patients with COVID 19 infection

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Ahmed Abu elfatth	Assuit University Hospitals	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Ahmed		Al Minyā	Alminya	71515	Egypt

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
32450785	Background	Peck-Radosavljevic M, Danese S, Hartmann D, Saftoiu A, Van Hootegem P; UEG Public Affairs Committee. COVID-19 and digestive health. United European Gastroenterol J. 2020 Jun;8(5):624-626. doi: 10.1177/2050640620927955. No abstract available.

ID	Term
D011024	Pneumonia, Viral
D011014	Pneumonia
D012141	Respiratory Tract Infections
D007239	Infections